www.antimicrobe.org

[Start Page] [Microbes] [Antimicrobial Agents] [HIV Clinical Manual] [Feedback] [Logout]

Clostridium difficile

 

Read the Chapter

Sliding Table of Contents on the left of the screen

 

 

Tables and Figures

Table 1: Randomized, Comparative Trials of Oral Therapy for Clostridium difficile Diarrhea

Table 2: Empirical Treatment Strategies for Patients with Multiple Recurrences of C. difficile Diarrhea

Table 3: Potential Future Treatment Options

Figure 1: Three Hit Disease

 

Vignettes

Bartlett JG.  Historical Perspectives on Studies of Clostridium difficile and C. difficile infection Clin Infect Dis 2008;46(Suppl 1):S4-S11.

Johnson, S, Schriever C, Galang M, Kelly CP, Gerding DN.  Interruption of recurrent Clostridium difficile-Associated Diarrhea Episodes by Serial Therapy with Vancomycin and Rifaximin. Clin Infect Dis 2007;44:846-848.

Bobulsky GS, Al-Nassir WN, et al. Clostridium difficile skin contamination in patients with C. difficile-associated disease. Clin Infect Dis 2008;46(3):447-50.

Redelings MD, Sorvillo F, Mascola L. Increase in Clostridium difficile-related Mortality Rates, United States, 1999-2004.  Emerg Infect Dis 2007;13:1417-1419.

Juang P, et al.  Clinical outcomes of intravenous immune globulin in severe clostridium difficile-associated diarrhea.  Am J Infect Control 2007;35:131-137.

Pepin J, Valiquette L, Gagnon S, Routhier S, Brazeau I.  Outcomes of Clostridium difficile-Associated Disease Treated with Metronidazole or Vancomycin Before and After the Emergency of NAP1/027.  Am J Gastroenterol 2007 Sep 27; [Epub ahead of print].

Bakken J Fecal Bacteriotherapy for Relapsing Clostridium difficile Infection. 2009

Zar FA, Bakkanagari SR, et al. A Comparison of Vancomycin and Metronidazole for the Treatment of Clostridium difficile-Associated Diarrhea, Stratified by Disease Severity. Clin Infect Dis. 2007;45:302-7. 

Lee NY, et al. Clostridium difficile Bacteremia, Taiwan.  Emerg Infect Dis 2010;16:1204-1210.

Tung JM, et al. Prevention of Clostridium difficile Infection with Saccharomyces boulardii: A Systematic Review. Can J Gastroenterol. 2009 Dec;23:817-21.

Guideline:  Cohen SH, et al.  Clinical Practice Guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and hte infectious diseases society of America (IDSA).  Infect Control Hosp Epidemiol (U.S.).  2010;31(5):431-455.

Review Article: McMaster-Baxter NL, Musher DM. Clostridium difficile: Recent Epidemiological Findings and Advances In Therapy.  Pharmacotherapy 2007;27(7):1029-1039.

 

Authors:

Hoonmo L. Koo, M.D., M.P.H. and Daniel M. Musher, M.D.

 

 

Author of Previous Edition:

 

Robert C. Owens, Jr., Pharm.D., Stuart Johnson, M.D., Dale N. Gerding, M.D.

 

 

 

www.antimicrobe.org

[Start Page] [Microbes] [Antimicrobial Agents] [HIV Clinical Manual] [Feedback] [Logout]